News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kite Pharma, Inc. Appoints Adrian Bot, M.D., Ph.D., as Chief Scientific Officer


7/11/2011 9:52:22 AM

LOS ANGELES--(BUSINESS WIRE)--Kite Pharma, Inc., a biopharmaceutical company focused on developing innovative active immunotherapies for cancer, announced today the appointment of Adrian Bot, M.D., Ph.D., as Chief Scientific Officer. Dr. Bot brings over 13 years of experience in the biopharmaceutical industry and expertise in discovery, research and development of active immunotherapies in oncology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES